238 related articles for article (PubMed ID: 6813993)
1. "Lupus" anticoagulant and thrombosis--possible role of inhibition of prostacyclin formation.
Carreras LO; Vermylen JG
Thromb Haemost; 1982 Aug; 48(1):38-40. PubMed ID: 6813993
[TBL] [Abstract][Full Text] [Related]
2. [Thrombotic phenomena and lupus anticoagulant in a series of 112 patients with systemic lupus erythematosus].
Ordi Ros J; Vilardell Tarrés M; Barquinero Máñez J; Selva O'Callaghan A; Alijotas Reig J; Bosch Gil J
Rev Clin Esp; 1987 Feb; 180(2):66-70. PubMed ID: 3105004
[No Abstract] [Full Text] [Related]
3. The lupus anticoagulant in systemic lupus erythematosus.
Rowell NR; Tate GM
Acta Derm Venereol; 1989; 69(2):111-5. PubMed ID: 2564226
[TBL] [Abstract][Full Text] [Related]
4. Surgery in patients with circulating lupus anticoagulant.
Shaulian E; Shoenfeld Y; Berliner S; Shaklai M; Pinkhas J
Int Surg; 1981; 66(2):157-9. PubMed ID: 6792105
[TBL] [Abstract][Full Text] [Related]
5. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death.
Carreras LO; Vermylen J; Spitz B; Van Assche A
Br J Obstet Gynaecol; 1981 Sep; 88(9):890-4. PubMed ID: 6791683
[TBL] [Abstract][Full Text] [Related]
6. [Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities].
Raleigh-Rosendo R; Diez-Ewald M; Vizcaíno G; Fereira H; Arteaga-Vizcaíno M; Arreaza M
Invest Clin; 1990; 31(1):45-55. PubMed ID: 2128614
[TBL] [Abstract][Full Text] [Related]
7. [Recurrent abortions and circulating anticoagulant. Relation to lupic disease: 6 cases].
Mathieu A; Piette JC; Blétry O; Conard J; Wechsler B; Le Bas J; Serdaru M; Godeau P
Ann Med Interne (Paris); 1984; 135(7):502-6. PubMed ID: 6517421
[TBL] [Abstract][Full Text] [Related]
8. [Lupus-type anticoagulants and thromboses].
Sultan Y
Ann Med Interne (Paris); 1986; 137(6):475-6. PubMed ID: 3101565
[TBL] [Abstract][Full Text] [Related]
9. [Lupus anticoagulant and recurrent transient ischemic attacks].
Guerrero A; García-Ruiz P; Bañares A; Rubio M; Escribá A; García-Urra D; Varela de Seijas E
Neurologia; 1989; 4(6):216-8. PubMed ID: 2517779
[TBL] [Abstract][Full Text] [Related]
10. [Lupus anticoagulant--its role and significance in the pathogenesis of thrombosis].
Styczyńska M; Chojnowski K; Matusewicz W; Krykowski E
Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):151-3. PubMed ID: 1437805
[No Abstract] [Full Text] [Related]
11. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus.
Ford PM; Ford SE; Lillicrap DP
J Rheumatol; 1988 Apr; 15(4):597-600. PubMed ID: 3135393
[TBL] [Abstract][Full Text] [Related]
12. [The lupus inhibitor].
Carreras LO; Vermylen J
Sangre (Barc); 1981; 26(5-A):610-8. PubMed ID: 6798699
[No Abstract] [Full Text] [Related]
13. Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant".
Asherson RA; Lanham JG; Hull RG; Boey ML; Gharavi AE; Hughes GR
Clin Exp Rheumatol; 1984; 2(1):75-9. PubMed ID: 6442640
[TBL] [Abstract][Full Text] [Related]
14. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
15. The clotting defect in SLE.
Byron MA
Clin Rheum Dis; 1982 Apr; 8(1):137-51. PubMed ID: 6811189
[TBL] [Abstract][Full Text] [Related]
16. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus.
de Prost D; Ollivier V; Ternisien C; Chollet-Martin S
Thromb Haemost; 1990 Oct; 64(2):216-21. PubMed ID: 2125372
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.
Boey ML; Colaco CB; Gharavi AE; Elkon KB; Loizou S; Hughes GR
Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1021-3. PubMed ID: 6412932
[TBL] [Abstract][Full Text] [Related]
18. An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity--a mechanism for thrombosis.
Freyssinet JM; Wiesel ML; Gauchy J; Boneu B; Cazenave JP
Thromb Haemost; 1986 Jun; 55(3):309-13. PubMed ID: 3018955
[TBL] [Abstract][Full Text] [Related]
19. [Brain stem infarction, systemic lupus erythematosus and circulating lupus anticoagulant].
Destée A; Devos P; Prin L; Warot M; Warot P
Rev Neurol (Paris); 1985; 141(3):236-9. PubMed ID: 3923592
[TBL] [Abstract][Full Text] [Related]
20. Thrombosis associated with antiphospholipid antibodies cannot be explained by effects on endothelial and platelet prostanoid synthesis.
Hasselaar P; Derksen RH; Blokzijl L; de Groot PG
Thromb Haemost; 1988 Feb; 59(1):80-5. PubMed ID: 3129812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
